Main issues in micronutrient supplementation in phenylketonuria
- PMID: 24018009
- DOI: 10.1016/j.ymgme.2013.08.008
Main issues in micronutrient supplementation in phenylketonuria
Abstract
For almost all patients with PKU, a low phenylalanine diet is the basis of the treatment despite a widely varying natural protein tolerance. A vitamin and mineral supplement is essential and it is commonly added to a phenylalanine-free (phe-free) source of L-amino acids. In PKU, many phe-free L-amino acid supplements have age-specific vitamin and mineral profiles to meet individual requirements. The main micronutrient sources are chemically derived and their delivery dosage is usually advised in three or more doses throughout the day. Within the EU, the composition of VM (vitamin and mineral) phe-free L-amino acid supplements is governed by the Foods for Special Medical Purposes (FSMP) directive (European Commission Directive number 1999/21/EC and amended by Directive 2006/141/EC). However the micronutrient composition of the majority fails to remain within FSMP micronutrient maximum limits per 100 kcal due to their low energy content and so compositional exceptions to the FSMP directive have to be granted for each supplement. All patients with PKU require an annual nutritional follow-up, until it has been proven that they are not at risk of any vitamin and mineral imbalances. When non-dietary treatments are used to either replace or act as an adjunct to diet therapy, the quality of micronutrient intake should still be considered important and monitored systematically. European guidelines are required about which micronutrients should be measured and the conditions (fasting status) for monitoring.
Keywords: Micronutrients; Minerals; Phenylalanine; Phenylketonuria; Vitamins.
© 2013.
Similar articles
-
Micronutrient status in phenylketonuria.Mol Genet Metab. 2013;110 Suppl:S6-17. doi: 10.1016/j.ymgme.2013.09.009. Epub 2013 Sep 19. Mol Genet Metab. 2013. PMID: 24113686 Review.
-
Vitamins and minerals: a model for safe addition to foods.Eur J Nutr. 2003 Apr;42(2):118-30. doi: 10.1007/s00394-003-0391-9. Eur J Nutr. 2003. PMID: 12638033
-
The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge.Ann Nutr Metab. 2014;65(1):42-8. doi: 10.1159/000363391. Epub 2014 Sep 4. Ann Nutr Metab. 2014. PMID: 25196394
-
Vitamin/mineral and micronutrient status in patients with classical phenylketonuria.Clin Nutr. 2019 Feb;38(1):197-203. doi: 10.1016/j.clnu.2018.01.034. Epub 2018 Feb 15. Clin Nutr. 2019. PMID: 29433755
-
Micronutrient requirements for athletes.Clin Sports Med. 2007 Jan;26(1):119-30. doi: 10.1016/j.csm.2006.11.009. Clin Sports Med. 2007. PMID: 17241918 Review.
Cited by
-
Potential Micronutrient Deficiencies in the First 1000 Days of Life: The Pediatrician on the Side of the Weakest.Curr Obes Rep. 2024 Jun;13(2):338-351. doi: 10.1007/s13679-024-00554-3. Epub 2024 Mar 21. Curr Obes Rep. 2024. PMID: 38512555 Free PMC article. Review.
-
A Cross-Sectional Study on Protein Substitutes for Paediatric Phenylketonuria Diet: Time to Pay Attention.Nutrients. 2025 May 23;17(11):1767. doi: 10.3390/nu17111767. Nutrients. 2025. PMID: 40507036 Free PMC article.
-
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.Orphanet J Rare Dis. 2016 Sep 9;11(1):123. doi: 10.1186/s13023-016-0508-x. Orphanet J Rare Dis. 2016. PMID: 27612877 Free PMC article.
-
Protein substitutes for phenylketonuria in Europe: access and nutritional composition.Eur J Clin Nutr. 2016 Jul;70(7):785-9. doi: 10.1038/ejcn.2016.54. Epub 2016 Apr 27. Eur J Clin Nutr. 2016. PMID: 27117930
-
Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.JIMD Rep. 2017;36:67-77. doi: 10.1007/8904_2016_39. Epub 2017 Jan 28. JIMD Rep. 2017. PMID: 28130717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical